Financials data is unavailable for this security.
View more
Year on year New Nordic Healthbrands AB had net income fall 119.45% from a loss of 2.82m to a larger loss of 6.20m despite a 9.51% increase in revenues from 487.50m to 533.85m. An increase in the selling, general and administrative costs as a percentage of sales from 12.36% to 13.12% was a component in the falling net income despite rising revenues.
| Gross margin | 64.96% |
|---|---|
| Net profit margin | -2.82% |
| Operating margin | -2.08% |
| Return on assets | -6.14% |
|---|---|
| Return on equity | -14.49% |
| Return on investment | -14.21% |
More ▼
Cash flow in SEKView more
In 2023, New Nordic Healthbrands AB increased its cash reserves by 29.06%, or 3.11m. The company earned 28.03m from its operations for a Cash Flow Margin of 5.25%. In addition the company used 3.40m on investing activities and also paid 21.17m in financing cash flows.
| Cash flow per share | -2.10 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 15.75 |
|---|---|
| Tangible book value per share | 14.83 |
More ▼
Balance sheet in SEKView more
| Current ratio | 1.57 |
|---|---|
| Quick ratio | 0.8299 |
| Total debt/total equity | 0.4655 |
|---|---|
| Total debt/total capital | 0.3177 |
More ▼
Growth rates in SEK
SmartText is unavailable
| Div yield(5 year avg) | 1.66% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -282.78 |
More ▼
